European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage.
Publish Articles Free
- Click to print (Opens in new window) Print
- Click to share on WhatsApp (Opens in new window) WhatsApp
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on X (Opens in new window) X
- Click to share on Publish Articles Free (Opens in new window) Publish Articles Free
- Click to share on LinkedIn (Opens in new window) LinkedIn
- More

